Mar 2026 - Rilemo completes the industrialization of the product’s functional components and starts the collaboration with Creanova, advancing the transition from device development to final product readiness and strengthening the company’s path toward scalable manufacturing
Feb 2026 - Rilemo participates in the first International Conference on Medical Microwave Imaging Applications (ICMWIA) in Lisbon, bringing its experience to the field and collaborating with peer groups to drive medical MWI toward broader clinical recognition and adoption
Nov 2025 - Rilemo takes part in MEDICA 2025 to present its next steps and engages with international medtech stakeholders, reinforcing the company’s positioning within the global shift toward point-of-care innovation
July 2025 - Rilemo secures ~€500k through a SAFE round backed by Business Angels, supporting core value-creation areas including regulatory strategy, pricing and financial planning
May 2025 - Rilemo’s final pre-industrialization prototype is validated on neurological human cadavers (ex-vivo) at the Trecchi Lab Institute (Cremona, IT)
Mar 2025 - Rilemo completes a clinical staff survey with 300+ in person interviews to validate market need & define the long term strategy at the European Congress of Radiology (ECR25)


Dec 2024 - Rilemo (ex. Previeni) wins €50.000 Grant from Fondazione UNIMI during Seed4Innovation
Nov 2024 - Rilemo demonstrates fluid detection capability compared with a CT scan in hospital settings with bovine animal ex-vivo samples
Sep 2024 - Rilemo enters into Bocconi 4 Innovation (B4i) Acceleration program securing a €50.000 Investment and incorporating as Rilemo S.r.l.
Jul 2024 - Rilemo (ex. Previeni) wins €10.000 Grant during the Unfold AI competition by Dock3
Jun 2024 - Rilemo completes a USA and East Europe tour to analyse the market state and future expansion strategy
May 2024 - Rilemo demonstrates fluid detection capability compared with a X-Ray in clinical settings with in-vitro synthetic samples based on real human MRI images
Apr 2024 - Rilemo (ex. Previeni) and Avertis merged to join forces with their common vision of fighting late and wrong diagnoses, complementing the team
Feb 2024 - Rilemo (ex. Previeni) and Avertis complete a user survey with 40+ in person interviews to validate market need & define the short term strategy at the European Congress of Radiology (ECR24)
2022 / 2023 - Rilemo (ex. Previeni) and Avertis win two successive Switch2Product startup challenge by PoliHub securing €30.000,00 in Grants
Sep 2022 - After in-depth interviews with Medical Doctors, Rilemo pivots on portable diagnostics and starts miniaturisation to obtain the first, backpack sized, prototype
Apr 2022 - The first image is taken by the technology demonstrator, showing the various fluids and tissues in the section of the wrist of a volunteer
Sep 2021 - Rilemo’s early research is awarded with a Technology Transfer Grant from the Italian National Institute for Nuclear Physics (INFN) to build a technology demonstrator
This Data Room is provided to you by:

Rilemo S.r.l.
Via Don Sebastiano Colleoni 20, Robbiate (LC), 23899, Italy
EU VAT: IT 04187140134 - ATECO: 26.60.02
PEC: - rilemo@legalmail.it


